Two heart disease medtech firms among Nasdaq debutants
This article was originally published in Clinica
Executive Summary
A flurry of end-of-year initial public offerings (IPOs) has included a handful of medical technology debutants. Conor Medsystems, which is developing a new design of drug-eluting stent aimed at providing better control over the release of the drug than existing drug-coated devices was the most recent.